Rankings
▼
Calendar
NAGE Q1 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$423M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+17.5% YoY
Gross Profit
$11M
61.0% margin
Operating Income
-$8M
-44.8% margin
Net Income
-$8M
-44.8% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
-2.8%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$53M
Total Liabilities
$27M
Stockholders' Equity
$26M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$15M
+17.5%
Gross Profit
$11M
$9M
+14.1%
Operating Income
-$8M
-$7M
-5.0%
Net Income
-$8M
-$7M
-4.9%
← FY 2022
All Quarters
Q2 2022 →